AndersonK.N., GlanzeW.D.Mosby's medical dictionary, nursing, and allied health.3rd ed.St. Louis (MO): Mosby; 1994.
2.
PelosofL.C., GerberD.E.Paraneoplastic syndromes: an approach to diagnosis and treatment.Mayo Clin Proc2010; 85(9): 838–854. doi: 10.4065/mcp.2010.0099.
3.
ZumstegM.M., CaspersonD.S.Paraneoplastic syndromes in metastatic disease.Semin Oncol Nurs1998; 14(3): 220–229.
CasciatoD.A., LowitzB.B.Manual of clinical oncology.3rd ed.Boston: Little, Brown; 1995.
9.
HansenH.H., PappotH.Primary malignant tumours of the lung and pleura. In: CavalliF., HansenH.H., KayeS.B., editors. Textbook of medical oncology.London: Martin Dunitz; 1997.
10.
OttoS.Oncology nursing.3rd ed.St Louis (MO): Mosby; 1997.
MacLeodR., Vella-BrincatJ., MacleodS.The palliative care handbook: guidelines for clinical management and symptom control.6th ed.Wellington: Genesis Oncology Trust; 2012.
13.
HeatleyS.Metastatic bone disease and tumour-induced hypercalcaemia: treatment options.Int J Palliat Nurs2004; 10(1): 41–46.
14.
ShermanF.T.Hyponatremia and SIADH in the elderly. Introducing the “water-offered test” for dehydration.Geriatrics2007; 62(7): 17–18.
15.
LangfeldtL.A., CooleyM.E.Syndrome of inappropriate antidiuretic hormone secretion in malignancy: review and implications for nursing management.Clin J Oncol Nurs2003; 7(4): 425–430.
16.
Van PoznakC.Hypercalcemia of malignancy remains a clinically relevant problem.Cancer J2006; 12(1): 21–23.
17.
CoukellA.J., MarkhamA.Pamidronate. A review of its use in the management of osteolytic bone metastases, tumour-induced hypercalcaemia, and Paget's disease of bone.Drugs Aging1998; 12(2): 149–168.
18.
Held-WarmkesselJ.Managing three critical cancer complications.Nursing2005; 35(1): 58–63.
19.
SilvérioR., AlcantaraP., OtochJ.P.Counteracting cancer cachexia-related inflammation: it takes systemic strategies to treat a systemic syndrome.Nutrition Ther Metabolism2012; 30(2): 51–58.
20.
BrueraE.ABC of palliative care. Anorexia, cachexia, and nutrition.BMJ1997; 315(7117): 1219–1222.
21.
McClellandM.T.Paraneoplastic syndromes related to lung cancer.Clin J Oncol Nurs2010; 14(3) 357–364. doi: 10.1188/10. CJON.357–364.
AlsirafyS.A., MesidyS.M., Abou-ElelaE.N.Naproxen test for neoplastic fever may reduce suffering.J Palliat Med2011; 14(5): 665–666. doi: 10.1089/jpm.2010.0402.
24.
MouradO., PaldaV., DetskyA.S.A comprehensive evidence-based approach to fever of unknown origin.Arch Intern Med2003; 163(5): 545–551.
25.
HamiF., TrotmanI.The treatment of sweating.Eur J Palliat Care1999; 6(6): 184–187.
26.
MaidaV.Nabilone for the treatment of paraneoplastic night sweats: a report of four cases.J Palliat Med2008; 11(6): 929–934. doi: 10.1089/jpm.2008.9880.
27.
TwycrossR.Sweating in advanced cancer.Indian J Palliat Care2004; 10(1): 1–11.
28.
ChangJ.C., GrossH.M.Utility of naproxen in the differential diagnosis of fever of undetermined origin in patients with cancer.Am J Med1984; 76(4): 597–603.